Collplant Biotechnologies Ltd (CLGN) — Capital Reinvestment Ratio
Latest as of September 2023:
0.04x
Collplant Biotechnologies Ltd (CLGN) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow ($6.78 Million) in capital expenditures ($243.00K). See Collplant Biotechnologies Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$6.78 Million
USD
Capital Expenditures
$243.00K
USD
Data as of
Sep 2023
Most recent filing
Collplant Biotechnologies Ltd Capital Reinvestment Ratio (2021–2021)
This chart tracks Collplant Biotechnologies Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Collplant Biotechnologies Ltd (2021–2021)
Year-by-year Capital Reinvestment Ratio for Collplant Biotechnologies Ltd from 2021 to 2021. For live market cap and broader valuation context, see market cap of Collplant Biotechnologies Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.57x | $2.50 Million | $1.43 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow